OLX-201A

N/A

Report date: 2022/01/30 09:28:28
NME

Base Information

Drug NameOLX-201A
Drug Alias NameOLX-201A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceConnective tissue growth factor inhibitors
TargetsConnective tissue growth factor
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOlix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesOlix Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A